Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center, established in 1975, is an independent, non-profit research institution dedicated to preventing, diagnosing, and treating cancer, HIV/AIDS, and other life-threatening diseases. Headquartered in Seattle, Washington, the center operates across 16 locations, serving as a hub for medical innovation and patient care. Its mission is rooted in scientific discovery and translating research into tangible health benefits, integrating cutting-edge research with clinical services.

With an employee range of 5,000-10,000 individuals, Fred Hutchinson Cancer Center fosters a collaborative environment for its extensive team of medical staff and scientists. This workforce drives groundbreaking research, including advancements in cancer therapy, HIV prevention, and vaccine development. The center's commitment to scientific excellence is evident in its continuous pursuit of knowledge and innovation. Explore the expertise and dedication of its personnel by visiting Meet Fred Hutchinson Cancer Center's team to learn more about the individuals shaping the future of medical research and patient outcomes.

The center's research focus encompasses critical areas like novel cancer treatments, proton therapy, and data modeling for disease eradication. It actively engages in clinical trials and educational programs to advance medical understanding and improve patient participation. Positioned within a competitive landscape of major healthcare and research institutions, Fred Hutchinson Cancer Center distinguishes itself through its specialized focus and significant contributions to oncology and infectious disease research. Its substantial revenue of $984.0M reflects its operational scale and impact.